GNTA — Genenta Science SpA Cashflow Statement
0.000.00%
Last trade - 00:00Annual cashflow statement for Genenta Science SpA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -5.53 | -8.48 | -11.6 | -8.91 | -6.53 |
| Depreciation | |||||
| Non-Cash Items | 0.51 | 0.813 | 0.816 | 0.91 | 1.21 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.94 | 0.24 | -0.418 | 1.72 | -1.58 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -6.96 | -7.42 | -11.2 | -6.24 | -6.87 |
| Capital Expenditures | -0.009 | -0.027 | -0.014 | -0.004 | -0.008 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | -14.9 | 6.89 | -14.5 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.009 | -0.027 | -14.9 | 6.88 | -14.5 |
| Financing Cash Flow Items | 0 | 0 | 0.001 | 0.271 | 14.8 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 28.7 | 0 | 0.001 | 0.271 | 22.3 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 21.8 | -7.45 | -26.1 | 0.89 | 0.946 |